نتائج البحث - "Felicia Roncolato"

1

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

المؤلفون: Martin R. Stockler, Jonathan S. Berek, Aikou Okamoto, Anne Lanceley, Elisabeth Åvall-Lundqvist, Luke Buizen, Jonathan A. Ledermann, Rachel O'Connell, Madeleine King, Dominique Berton-Rigaud, Paul Donnellan, Michael Friedlander, Domenica Lorusso, Eriko Aotani, Jalid Sehouli, Amit M. Oza, Marie Christine Kaminsky, Felix Hilpert, Felicia Roncolato

المصدر: Gynecologic Oncology. 148:36-41

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, medicine.medical_specialty, ECOG Performance Status, Severity of Illness Index, Prognostic score, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Prospective Studies, Serum Albumin, Aged, Platinum resistant, Ovarian Neoplasms, Health related quality of life, Performance status, biology, business.industry, C-reactive protein, Reproducibility of Results, Obstetrics and Gynecology, Middle Aged, Prognosis, humanities, Surgery, Clinical trial, C-Reactive Protein, 030104 developmental biology, ROC Curve, Recurrent Ovarian Cancer, 030220 oncology & carcinogenesis, biology.protein, Female, Neoplasm Recurrence, Local, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c05ed37a5993e967620e7dc19b4715e
https://doi.org/10.1016/j.ygyno.2017.10.019

View record from ScienceDirect

Full Text via ClinicalKey

2

Ipilimumab + nivolumab in people with rare variant renal cell carcinoma refractory to nivolumab alone: Part 2 of UNISON (ANZUP 1602) nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma

المصدر: Journal of Clinical Oncology. 39:4565-4565

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer, Ipilimumab, Immunotherapy, medicine.disease, Clear cell renal cell carcinoma, Refractory, Renal cell carcinoma, Internal medicine, Medicine, Nivolumab, business, Kidney disease, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::567830202f3797b10e7543c383e56e2c
https://doi.org/10.1200/jco.2021.39.15_suppl.4565

3

Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy

المؤلفون: Felix Hilpert, Madeleine King, Martin R. Stockler, Lucy Claire Davies, Val Gebski, Felicia Roncolato, Michael Friedlander, Eric Pujade-Lauraine, Rebecca Asher, Chee Khoon Lee, Emma Gibbs, Lari Wenzel

المصدر: Annals of Oncology. 28:1849-1855

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073722be6451d3899df8bd3f0d58cfbf
https://doi.org/10.1093/annonc/mdx229

4

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)

المؤلفون: Madeleine King, Luke Buizen, Martin R. Stockler, Florence Joly, F. Hilpert, C. Roemer-Becuwe, Vanda Salutari, Jonathan S. Berek, Amit M. Oza, Anne Lanceley, Paul Donnellan, Felicia Roncolato, Jonathan A. Ledermann, Michael Friedlander, Tanja Fehm, Elizabeth Åvall-Lundqvist, Aikou Okamoto, Rachel O'Connell, Eriko Aotani

المصدر: Gynecologic oncology. 156(1)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ff58950d76f37c31ace99658c4d301f
https://pubmed.ncbi.nlm.nih.gov/31836184

View record from ScienceDirect

Full Text via ClinicalKey

5

Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer

المؤلفون: Martin R. Stockler, Felicia Roncolato, R. J. Simes, Andrew J. Martin, Nicola Jane Lawrence

المصدر: JNCI Cancer Spectrum

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e9b82ad4b04a830e94dd6cd2bfac7d
https://doi.org/10.1093/jncics/pky037

6

DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)—A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation

المصدر: Journal of Clinical Oncology. 39:TPS266-TPS266

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Urology, Placebo-controlled study, Cancer, medicine.disease, Radiation therapy, Androgen deprivation therapy, medicine.anatomical_structure, Darolutamide, Oncology, Prostate, medicine, business, Luteinizing hormone, Hormone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e82b1a15824d149fce95dbbd3f7375de
https://doi.org/10.1200/jco.2021.39.6_suppl.tps266

7

UNISON - nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1—Nivolumab monotherapy

المصدر: Journal of Clinical Oncology. 39:325-325

مصطلحات موضوعية: Cancer Research, business.industry, Immune checkpoint inhibitors, Ipilimumab, medicine.disease, Clinical trial, Clear cell renal cell carcinoma, Oncology, Renal cell carcinoma, medicine, Cancer research, Nivolumab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::23eececc9b164bc60587f256669390c5
https://doi.org/10.1200/jco.2021.39.6_suppl.325

8

The effect of pulmonary function testing on bleomycin dosing in germ cell tumours

المؤلفون: Guy C. Toner, Howard Gurney, M. Rosenthal, Mark D. Chatfield, Peter Grimison, Baerin Houghton, Martin R. Stockler, Michael Friedlander, Felicia Roncolato, Damien Thomson

المصدر: Internal Medicine Journal. 46:893-898

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::72a78ed97edc3e9eede8cf555903e8a6
https://doi.org/10.1111/imj.13158

View record at Wiley

9

Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC)

المؤلفون: Mark Salvati, Shirley Poon, Rohan Garje, Shahrokh F. Shariat, Karen A. Autio, Felicia Roncolato, Richard Greil, Karim Fizazi, Ben Tran, Jean-Pascal Machiels, Martijn P. Lolkema, Tanya B. Dorff, Matthew Rettig, Scott T. Tagawa, Sylvie Rottey, Nabil Adra, Lisa G. Horvath, Hosein Kouros-Mehr

المصدر: Journal of Clinical Oncology. 38:TPS5590-TPS5590

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5b8ca6dd3caa929c077fc7c2d9ea8e5c
https://doi.org/10.1200/jco.2020.38.15_suppl.tps5590

10

DASL-HiCAP (ANZUP1801): The impact of darolutamide on standard therapy for localized very high-risk cancer of the prostate—A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high-risk, clinically localized prostate cancer

المؤلفون: Simon Hughes, Karen Bracken, Margot Gorzeman, James W.F. Catto, Scott Williams, Martin R. Stockler, Neha Vapiwala, Raymond S. McDermott, Andrew J. Martin, Wendy Hague, Christopher Sweeney, Lisa G. Horvath, Tamim Niazi, Ian D. Davis, Shomik Sengupta, Sonia Yip, Felicia Roncolato, Wendy R. Parulekar

المصدر: Journal of Clinical Oncology. 38:TPS385-TPS385

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::20b2b4e2f85ae3f6aa9ae8331f996196
https://doi.org/10.1200/jco.2020.38.6_suppl.tps385

تنقيح النتائج